215 studies found for:    Open Studies | "Fatty Acids, Omega-3"
Show Display Options
Rank Status Study
21 Recruiting OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer
Condition: Pediatric Cancer
Intervention: Dietary Supplement: Omega-3 enriched fruit juice
22 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
23 Recruiting Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents
Conditions: Obesity;   Insulin Resistance
Interventions: Dietary Supplement: Omega3 and an hypocaloric diet.;   Dietary Supplement: Sunflower oil with an hypocaloric diet.
24 Not yet recruiting Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognition
Interventions: Drug: Alpha lipoic acid and omega-3 fatty acids;   Drug: Placebo
25 Unknown  The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: Omega 3;   Other: Physical Training
26 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
27 Recruiting A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients
Condition: T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Interventions: Drug: placebo;   Drug: Omega-3 carboxylic acids;   Drug: Dapagliflozin;   Drug: Placebo
28 Recruiting n-3 PUFA for Vascular Cognitive Aging
Conditions: Age Related Cognitive Decline;   Alzheimer's Disease;   Vascular Dementia;   Endothelial Dysfunction;   Executive Dysfunction
Interventions: Drug: Omega 3 PUFA;   Drug: Placebo
29 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator
30 Not yet recruiting Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate
Condition: Whole Body Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
31 Unknown  The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Membrane Composition and Cellular Metabolism
Condition: Skeletal Muscle Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
32 Recruiting Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function
Condition: Morbid Obesity
Interventions: Drug: Omega-3 fatty acid capsules;   Behavioral: Low calorie diet
33 Recruiting Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Dietary Supplement: Omega-3 Fatty Acids;   Dietary Supplement: Medium Chain Triglycerides
34 Not yet recruiting The Correlation Between Blood omega3 and ADHD
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Procedure: blood test;   Dietary Supplement: omega3 capsules
35 Recruiting Omega-3 Supplementation for Smell Dysfunction
Conditions: Sellar/Parasellar Tumor;   Smell Dysfunction
Intervention: Dietary Supplement: Omega-3
36 Recruiting Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
Conditions: Attention Deficit Disorder With Hyperactivity;   ADHD Inattention or Mixed Type;   Epilepsy;   Child
Interventions: Drug: Vayarin®, supplementation of n-3 PUFA;   Drug: PLACEBO
37 Unknown  Feasibility of Omega-3 Supplementation for Children With Language Impairments
Condition: Language Impairment
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Placebo
38 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Condition: Hyperlipidemia, Familial Combined
Interventions: Drug: Atorvastatin 20mg;   Drug: Omega-3-acids ethylesters 90 4g;   Other: Placebo(Omega-3-acids ethylesters 90)
39 Unknown  Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
Condition: Autism
Interventions: Dietary Supplement: Omega 3 fatty acids;   Other: Placebo
40 Recruiting Effects of Marine n-3 Fatty Acids on Heart Rate Variability and Arrhythmias in Patients Receiving Chronic Dialysis
Conditions: Kidney Failure Chronic;   Arrhythmias Cardiac
Interventions: Dietary Supplement: dietary supplement: n-3 PUFA;   Dietary Supplement: olive oil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years